Sign in Register

Drug class

Opioid Analgesics- IR (with all antitussive opiates)

"Opioid Analgesics- IR (with all antitussive opiates)" is a specific drug classification and clinical decision-support grouping used in commercial electronic health record and formulary databases—such as First Databank—rather than a standard formal pharmacological class recognized by regulatory bodies like the FDA. Read more about Opioid Analgesics- IR (with all antitussive opiates)

547 drugs in this class 152 manufacturers

Advertisement

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs PainTop indication · 657 prescription drugs

Drugs in Opioid Analgesics- IR (with all antitussive opiates)

Showing 469–477 of 547 drugs

MORPHINE SULFATE

OPIOID ANALGESICS- IR (WITH ALL ANTITUSSIVE OPIATES) · SEVERE PAIN WITH OPIOID TOLERANCE
SpecGx

OXYCODONE HCL

OPIOID ANALGESICS- IR (WITH ALL ANTITUSSIVE OPIATES) · PAIN
SpecGx

BELBUCA (buprenorphine HCl)

OPIOID ANALGESICS- ER (WITH ALL ANTITUSSIVE OPIATES) · SEVERE CHRONIC PAIN REQUIRING LONG-TERM OPIOID TREATMENT
BIODEL/COLLEGIU
Filter & compare in the drug finder → Opens the drug finder with Opioid Analgesics- IR (with all antitussive opiates) preselected. Add indication or manufacturer filters there.

About Opioid Analgesics- IR (with all antitussive opiates).

"Opioid Analgesics- IR (with all antitussive opiates)" is a specific drug classification and clinical decision-support grouping used in commercial electronic health record and formulary databases—such as First Databank—rather than a standard formal pharmacological class recognized by regulatory bodies like the FDA.

It aggregates immediate-release (IR) opioid formulations alongside opiate-based cough suppressants, including agents such as codeine, hydrocodone, morphine, and levorphanol.

Pharmacologically, these agents act primarily as agonists at central nervous system mu-opioid receptors to modulate nociceptive signaling and suppress the medullary cough reflex.

Consequently, this administrative grouping captures medications used in clinical practice for the management of acute or breakthrough moderate-to-severe pain and the symptomatic relief of severe, intractable cough.